Indian drugmaker Alivus Life Sciences , formerly called Glenmark Life Sciences, reported a higher third-quarter profit on Thursday, driven by strong demand in its mainstay active pharmaceutical ingredients (API) business.
Jan 22 (Reuters) – Indian drugmaker Alivus Life Sciences (ALIV.NS), opens new tab, formerly called Glenmark Life Sciences, reported a higher third-quarter profit on Thursday, driven by strong demand in its mainstay active pharmaceutical ingredients (… [1186 chars]
Source: Reuters | Published: 2026-01-22T08:49:54Z
Credit: Reuters
